Orphan Well Grant Flexibility Act of 2024

Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for H.R.7327 - Protecting Front Line Multimission Hospitals Act of 2024. Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions, in general. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; and S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023.

Client expense: $130,000 · Firm income: Not reported

H.R.21: Strategic Production Response Act H.R.1335: Transparency, Accountability, Permitting, and Production of American Resources Act H.R.1043: To restore onshore energy production H.R.1205: Bureau of Land Management Mineral Spacing Act H.R.1430: Determination of NEPA Adequacy Streamlining Act H.R.1577: Building United States Infrastructure through Limited Delays and Efficient Reviews Act of 2023 H.R. 4301: Bonding Reform and Taxpayer Protection Act of 2023 S.31: SPR Act H.R.1362: Saving Americas Energy Future Act S.535: Bureau of Land Management Mineral Spacing Act S.879: Energy Freedom Act S.19: FRESH Act H.R. 3746: Fiscal Responsibility Act of 2023 S 1863: PROVE IT Act HR 7375: Amend the Mineral Leasing Act to improve the assessment of expression of interest fees, and for other purposes. HR 7377: Royalty Resiliency Act H.R. 7053: Orphan Well Grant Flexibility Act of 2024 S. 4753: Energy Permitting Reform Act of 2024 Issues related to multiple use land management and permitting

Client expense: $120,000 · Firm income: Not reported

Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for H.R.7327 - Protecting Front Line Multimission Hospitals Act of 2024. Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services.

Client expense: Not reported · Firm income: $40,000

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; and S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023.

Client expense: $130,000 · Firm income: Not reported

H.R.21: Strategic Production Response Act H.R.1335: Transparency, Accountability, Permitting, and Production of American Resources Act H.R.1043: To restore onshore energy production H.R.1205: Bureau of Land Management Mineral Spacing Act H.R.1430: Determination of NEPA Adequacy Streamlining Act H.R.1577: Building United States Infrastructure through Limited Delays and Efficient Reviews Act of 2023 H.R. 4301: Bonding Reform and Taxpayer Protection Act of 2023 S.31: SPR Act H.R.1362: Saving Americas Energy Future Act S.535: Bureau of Land Management Mineral Spacing Act S.879: Energy Freedom Act S.19: FRESH Act H.R. 3746: Fiscal Responsibility Act of 2023 S 1863: PROVE IT Act HR 7375: Amend the Mineral Leasing Act to improve the assessment of expression of interest fees, and for other purposes. HR 7377: Royalty Resiliency Act H.R. 7053: Orphan Well Grant Flexibility Act of 2024 Issues related to multiple use land management and permitting

Client expense: $170,000 · Firm income: Not reported

Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. Consolidated Appropriations Act, Fiscal Year 2024 - provisions to address Medicare physician fee schedule payment policies and access to physician services.

Client expense: Not reported · Firm income: $50,000

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024, and H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024 and H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024.

Client expense: $140,000 · Firm income: Not reported

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; and H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024.

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act.

Client expense: Not reported · Firm income: $50,000

Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; and H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R.7053/S.3792 - acute hospital care at home waiver flexibility; H.R. 2617, the Consolidated Appropriations Act of 2023; H.R.1613, Drug Price Transparency in Medicaid Act of 2023; H.R.2665, Supporting Safety Net Hospitals Act; H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.

Client expense: Not reported · Firm income: $50,000

Drug Origin Transparency Act of 2023 (H.R. 3810); Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees (H.R. 1770); Equitable Community Access to Pharmacist Services Act (H.R. 7053); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 2617, the Consolidated Appropriations Act of 2023; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; and H.R. 2617, the Consolidated Appropriations Act of 2023.

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support for issues regarding recognition of uncompensated are costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R.7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R.5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R.7053/S.3792 - acute hospital care at home waiver flexibility; policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; H.R.2617, the Consolidated Appropriations Act, 2023.

Client expense: Not reported · Firm income: $40,000

Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees-H.R. 1770; Equitable Community Access to Pharmacist Services Act-H.R. 7053; VALID Act; Saving Access to Laboratory Services Act (SALSA); Issues related to Medicare provider cuts; Issues related to glucose monitors; Issues related to billing codes.

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues relating to extension of the Acute Hospital Care at Home (AHCAH) waiver program, and the creation of a pathway to coverage for advanced care at home services including H.R. 7053/S. 3792.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE